序号 |
标题 |
次数 |
作者 |
发布时间 |
82756 |
DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 |
160 |
wyh |
2024-12-03 |
82757 |
DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO |
117 |
wyh |
2024-12-03 |
82758 |
甲氧基DOTA ,MeO-DOTA |
211 |
wyh |
2024-12-03 |
82759 |
DOTA-BASS , DOTA偶联sst拮抗剂 |
207 |
wyh |
2024-12-03 |
82760 |
DOTA-phenylalanine,DOTA-苯丙氨酸 |
118 |
wyh |
2024-12-03 |
82761 |
DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 |
112 |
wyh |
2024-12-03 |
82762 |
DOTA-GA,螯合剂DOTA肽缀合物 |
135 |
wyh |
2024-12-03 |
82763 |
DOTA共轭二膦酸盐,DOTA-HBP |
129 |
wyh |
2024-12-03 |
82764 |
DOTA-神经介素n ,DOTA-Neuromedin N |
109 |
wyh |
2024-12-03 |
82765 |
tris-烯丙基-DOTA , tris-allyl-DOTA |
92 |
wyh |
2024-12-03 |
82766 |
6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine |
114 |
WYQ |
2024-12-03 |
82767 |
6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine |
134 |
WYQ |
2024-12-03 |
82768 |
cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA |
83 |
wyh |
2024-12-03 |
82769 |
6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine |
115 |
WYQ |
2024-12-03 |
82770 |
MMA-DOTA-Cys 61 ,DOTA-马来酰亚胺-半胱氨酸 |
141 |
wyh |
2024-12-03 |
82771 |
DOTA-BR96 ,DOTA标记BR96单克隆抗体 |
114 |
wyh |
2024-12-03 |
82772 |
DOTA-ggNle-cycmsh(hex),内酰胺桥环化肽偶联DOTA |
104 |
wyh |
2024-12-03 |
82773 |
DOTA-sCCK8[Phe2(p-CH2SO3H) ,大环DOTA偶联多肽 |
107 |
wyh |
2024-12-03 |
82774 |
3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪(BTATz);3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)- 1,2,4,5-tetrazine |
117 |
WYQ |
2024-12-03 |
82775 |
3,3'-偶氮二(6-氨基-1,2,4,5-四嗪)(DAAT);3,3'-azobis(6-amino-1,2,4,5-tetrazine) |
222 |
WYQ |
2024-12-03 |
82776 |
c(DOTA-RGDf),大环螯合剂DOTA环化RGD肽序列 |
114 |
wyh |
2024-12-03 |
82777 |
3,6-双(吡啶-3-基)-1,2,4,5-四嗪(3,3'-吡喃);3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) |
118 |
WYQ |
2024-12-03 |
82778 |
3,6-双(2-甲氧基苯基)-1,2-二氢-1,2,4,5-四嗪(2-MDHT);3,6-bis(2-methoxyphenyl)-1,2-dihydro-1,2,4,5-tetrazine |
131 |
WYQ |
2024-12-03 |
82779 |
3,6-二甲基-1,2,4,5-四嗪;3,6-Dimethyl-1,2,4,5-tetrazine |
130 |
WYQ |
2024-12-03 |
82780 |
3,3'-偶氮(6-氨基-1,2,4,5-四嗪);3,3'-Azobis(6-amino-1,2,4,5-tetrazine)(DAAT) |
160 |
WYQ |
2024-12-03 |
82781 |
3,6-d二肼基-1,2,4,5-四嗪(DHT) |
118 |
WYQ |
2024-12-03 |
82782 |
DOTA-D-phe1-Tyr3-奥曲肽 ,Ga-68-DOTA-TATE |
98 |
wyh |
2024-12-03 |
82783 |
DOTA-cCCK,DOTA偶联胆囊收缩素(CCK)受体 |
125 |
wyh |
2024-12-03 |
82784 |
3,6-d氨基-1,2,4,5-四嗪(DATZ) |
115 |
WYQ |
2024-12-03 |
82785 |
3-d氨基-6-(3,5-二甲基乙基吡唑-1-基)-1,2,4,5-四嗪(ADMPT) |
138 |
WYQ |
2024-12-03 |
82786 |
[DOTA]LTT-SS28 ,生长抑素模拟物 |
144 |
wyh |
2024-12-03 |
82787 |
DOTA-minigastrin (CP04) , DOTA-小胃泌素(CP04) |
153 |
wyh |
2024-12-03 |
82788 |
DOTA-rhuEpo ; DOTA-酰肼偶联rhuEpo |
94 |
wyh |
2024-12-03 |
82789 |
1,2,4,5-四嗪 , 化学式:C2H2N4 |
178 |
WYQ |
2024-12-03 |
82790 |
DOTA-Benerotide ;靶向生长抑素受体 |
87 |
wyh |
2024-12-03 |
82791 |
1,2,4,5-Tetrazines by Palladium Catalysis(钯催化1,2,4,5-四嗪的合成) |
105 |
WYQ |
2024-12-03 |
82792 |
5-苯基-1,2,4-三嗪-3-胺为例,为C9H8N4 |
103 |
WYQ |
2024-12-03 |
82793 |
DOTA-PEG-LA-AuNP,DOTA-PEG-硫辛酸修饰纳米金纳米粒子 |
121 |
wyh |
2024-12-03 |
82794 |
3,6-二(吡啶-2-基)-1,2,4,5-四嗪(pytz) |
151 |
WYQ |
2024-12-03 |
82795 |
HYNIC-PEG11-Tz;联肼尼克酰胺-十一聚乙二醇-四嗪;HYNIC-PEG11-Tetrazine |
100 |
WYQ |
2024-12-03 |
82796 |
DOTA-NT肽偶联金纳米粒子 ,DOTA-NT-AuNPs |
105 |
wyh |
2024-12-03 |
82797 |
[Zr-89]Zr-DFO-PEG5-Tz;[Zr-89]Zr-DFO-PEG5-Tetrazine |
113 |
WYQ |
2024-12-03 |
82798 |
MeTz-NOTA-RGD;甲基四嗪-大环配体-多肽 |
148 |
WYQ |
2024-12-03 |
82799 |
DOTA-Tyr(3)-奥曲肽, DOTA-Tyr(3)-Octreotide |
87 |
wyh |
2024-12-03 |
82800 |
AgNPs–pytz(3,6-二(吡啶-2-基)-1,2,4,5-四嗪包覆的银纳米粒子) |
105 |
WYQ |
2024-12-03 |